156 related articles for article (PubMed ID: 28057529)
1. Genetic inhibition of Anaplastic Lymphoma Kinase rescues cognitive impairments in Neurofibromatosis 1 mutant mice.
Weiss JB; Weber SJ; Torres ERS; Marzulla T; Raber J
Behav Brain Res; 2017 Mar; 321():148-156. PubMed ID: 28057529
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological inhibition of Anaplastic Lymphoma Kinase rescues spatial memory impairments in Neurofibromatosis 1 mutant mice.
Weiss JB; Weber S; Marzulla T; Raber J
Behav Brain Res; 2017 Aug; 332():337-342. PubMed ID: 28629962
[TBL] [Abstract][Full Text] [Related]
3. Role of the parental NF1 carrier in effects of pharmacological inhibition of anaplastic lymphoma kinase in Neurofibromatosis 1 mutant mice.
Krenik D; Weiss JB; Raber J
Brain Res; 2021 Oct; 1769():147594. PubMed ID: 34339711
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of pharmacological inhibition of anaplastic lymphoma kinase in neurofibromatosis 1 mutant mice.
Krenik D; Weiss JB; Raber J
Behav Brain Res; 2022 Apr; 423():113767. PubMed ID: 35077772
[TBL] [Abstract][Full Text] [Related]
5. Anaplastic Lymphoma Kinase Acts in the Drosophila Mushroom Body to Negatively Regulate Sleep.
Bai L; Sehgal A
PLoS Genet; 2015 Nov; 11(11):e1005611. PubMed ID: 26536237
[TBL] [Abstract][Full Text] [Related]
6. Genetic and functional studies implicate synaptic overgrowth and ring gland cAMP/PKA signaling defects in the Drosophila melanogaster neurofibromatosis-1 growth deficiency.
Walker JA; Gouzi JY; Long JB; Huang S; Maher RC; Xia H; Khalil K; Ray A; Van Vactor D; Bernards R; Bernards A
PLoS Genet; 2013 Nov; 9(11):e1003958. PubMed ID: 24278035
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Anaplastic Lymphoma Kinase (Alk) as Therapeutic Target to Improve Brain Function in Neurofibromatosis Type 1 (Nf1).
Weiss JB; Raber J
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760547
[TBL] [Abstract][Full Text] [Related]
8. Jelly Belly trans-synaptic signaling to anaplastic lymphoma kinase regulates neurotransmission strength and synapse architecture.
Rohrbough J; Kent KS; Broadie K; Weiss JB
Dev Neurobiol; 2013 Mar; 73(3):189-208. PubMed ID: 22949158
[TBL] [Abstract][Full Text] [Related]
9. Anaplastic lymphoma kinase and leukocyte tyrosine kinase: functions and genetic interactions in learning, memory and adult neurogenesis.
Weiss JB; Xue C; Benice T; Xue L; Morris SW; Raber J
Pharmacol Biochem Behav; 2012 Jan; 100(3):566-74. PubMed ID: 22079349
[TBL] [Abstract][Full Text] [Related]
10. A mouse model for the learning and memory deficits associated with neurofibromatosis type I.
Silva AJ; Frankland PW; Marowitz Z; Friedman E; Laszlo GS; Cioffi D; Jacks T; Bourtchuladze R
Nat Genet; 1997 Mar; 15(3):281-4. PubMed ID: 9054942
[TBL] [Abstract][Full Text] [Related]
11. Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1.
Costa RM; Federov NB; Kogan JH; Murphy GG; Stern J; Ohno M; Kucherlapati R; Jacks T; Silva AJ
Nature; 2002 Jan; 415(6871):526-30. PubMed ID: 11793011
[TBL] [Abstract][Full Text] [Related]
12. The receptor tyrosine kinase Alk controls neurofibromin functions in Drosophila growth and learning.
Gouzi JY; Moressis A; Walker JA; Apostolopoulou AA; Palmer RH; Bernards A; Skoulakis EM
PLoS Genet; 2011 Sep; 7(9):e1002281. PubMed ID: 21949657
[TBL] [Abstract][Full Text] [Related]
13. The ligand Jelly Belly (Jeb) activates the Drosophila Alk RTK to drive PC12 cell differentiation, but is unable to activate the mouse ALK RTK.
Yang HL; Eriksson T; Vernersson E; Vigny M; Hallberg B; Palmer RH
J Exp Zool B Mol Dev Evol; 2007 May; 308(3):269-82. PubMed ID: 17285636
[TBL] [Abstract][Full Text] [Related]
14. HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.
Omrani A; van der Vaart T; Mientjes E; van Woerden GM; Hojjati MR; Li KW; Gutmann DH; Levelt CN; Smit AB; Silva AJ; Kushner SA; Elgersma Y
Mol Psychiatry; 2015 Nov; 20(11):1311-21. PubMed ID: 25917366
[TBL] [Abstract][Full Text] [Related]
15. Neurofibromatosis type 1 alternative splicing is a key regulator of Ras/ERK signaling and learning behaviors in mice.
Nguyen HT; Hinman MN; Guo X; Sharma A; Arakawa H; Luo G; Lou H
Hum Mol Genet; 2017 Oct; 26(19):3797-3807. PubMed ID: 28934393
[TBL] [Abstract][Full Text] [Related]
16. Paired associate learning in children with neurofibromatosis type 1: implications for clinical trials.
Payne JM; Barton B; Shores EA; North KN
J Neurol; 2013 Jan; 260(1):214-20. PubMed ID: 22875098
[TBL] [Abstract][Full Text] [Related]
17. MEK inhibitor trametinib does not prevent the growth of anaplastic lymphoma kinase (ALK)-addicted neuroblastomas.
Umapathy G; Guan J; Gustafsson DE; Javanmardi N; Cervantes-Madrid D; Djos A; Martinsson T; Palmer RH; Hallberg B
Sci Signal; 2017 Nov; 10(507):. PubMed ID: 29184034
[TBL] [Abstract][Full Text] [Related]
18. Impairment of Procedural Learning and Motor Intracortical Inhibition in Neurofibromatosis Type 1 Patients.
Zimerman M; Wessel MJ; Timmermann JE; Granström S; Gerloff C; Mautner VF; Hummel FC
EBioMedicine; 2015 Oct; 2(10):1430-7. PubMed ID: 26629537
[TBL] [Abstract][Full Text] [Related]
19. Characterization of early communicative behavior in mouse models of neurofibromatosis type 1.
Maloney SE; Chandler KC; Anastasaki C; Rieger MA; Gutmann DH; Dougherty JD
Autism Res; 2018 Jan; 11(1):44-58. PubMed ID: 28842941
[TBL] [Abstract][Full Text] [Related]
20. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
Gottfried ON; Viskochil DH; Couldwell WT
Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
